InvestorsHub Logo
Followers 211
Posts 32266
Boards Moderated 1
Alias Born 06/30/2009

Re: MackG post# 403011

Friday, 06/14/2024 11:36:26 AM

Friday, June 14, 2024 11:36:26 AM

Post# of 403306
It's safe to assume that you read the brief sentence that immediately preceded the one that you quoted, isn't it?
Just in case, it was:
"Brilacidin is in human Phase 2 trials."

A patently false statement in a dissertation is at the very least risky business on the part of the author. Its appearance in a paper prepared under the guidance and supervision of an IPIX Scientific Advisor is unconscionable. Stranger still is the fact that the statement is in a paper funded in part by Innovation Pharmaceuticals. Several connected parties theoretically knew that the statement was false and it was as false on the date of publication as it is today.

How did it get past the multiple reviews that I thought papers like this typically get?

No matter what it is or who commenced it, I'm against it!
....Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News